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doi:10.1016/j.ejvs.2009.11.003Abstract Background: Attempts to stratify carotid plaques according to clinical risk using
single longitudinal view (SLV) echomorphology have not been uniformly successful. We
compared SLV grey scale median measurements (SLV-GSM) with a newer technique of multiple
cross-sectional view echomorphology (MCSV-GSM) in carotid plaques from 3 patient groups
(asymptomatic, ocular, and hemispheric symptoms).
Methods: SLV and MCSV images were obtained from 109 carotid stenoses (70e99%; 41 hemi-
spheric, 17 ocular, 51 asymptomatic). SLV-GSM and MCSV-GSMmin (lowest plaque MCSV image
GSM) were determined to assess echolucency whilst MCSV-GSMmaxmin (highest minus lowest
MCSV-GSM) assessed heterogeneity.
Results: Echolucency was greater (lower GSM) in plaques causing hemispheric symptoms versus
asymptomatic plaques (MCSV-GSMmin, P Z .002; SLV-GSM, P Z .002). Only MCSV imaging de-
tected differences in echolucency between asymptomatic plaques and those causing ocular
symptoms (SLV-GSM, pZ 0.84; MCSV-GSMmin, pZ .003). Symptomatic plaques showed greater
heterogeneity versus asymptomatic plaques, significantly in those causing ocular symptoms
(hemispheric P Z .126; AF P Z .011).
Conclusions: Both SLV and MCSV echomorphology confirm increased echolucency in plaques
causing hemispheric symptoms. Plaques causing ocular symptoms could only be distinguished
from asymptomatic plaques with MCSV assessment (increased echolucency and heteroge-
neity). This suggests that amaurosis fugax may be associated with a more focal plaque insta-
bility that is best detected with MCSV imaging.
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Stroke remains a leading cause of death and disability in the
UK. Carotid endarterectomy (CEA) confers an advantage
over best medical therapy in prevention of stroke for both
high grade symptomatic1 and asymptomatic2,3 carotid
stenoses. However, using severity of stenosis as the only
criterion for selection of surgical candidates, the number
needed to treat to prevent one stroke is 6 and 19 for
symptomatic disease (at 5 years) and asymptomatic disease
(at 4 years) respectively. Further, outcome from CEA or
carotid stenting (CAS) may be influenced by plaque
composition, as early CEA is associated with increased risk
of peri-operative stroke and death4 and CAS for plaques
with a low GSM appears more hazardous.5
Identification of factors other than severity of stenosis
which are markers for either reduced risk of stroke with
best medical therapy or increased peri-operative risk would
clearly improve the risk : benefit of CEA or CAS. Risk of
stroke following transient ischaemic attack (TIA) is, in part,
determined by the symptomatology of the event, with
ocular symptoms carrying half the risk of hemispheric
symptoms.6 This is supported by validation of the ABCD2
score which grades reduced risk for ocular compared to
hemispheric symptoms7. Objective carotid plaque echo-
morphology as determined by grey scale median (GSM)
assessment has been associatedwith symptomatic status,8e11
cerebral infarcts on CT,12,13 microembolisation detected
by transcranial Doppler14 and increased risk of stroke
during CAS.5 Studies assessing the relationship of carotid
plaque echomorpholgy with presenting symptoms using
a single longitudinal view (SLV) have produced varying
results,15,16 perhaps because atheroma may be deposited
in an eccentric manner and because the image selected
for a single longitudinal view (providing global data on
plaque echomorphology) may not be truly representative
of the plaque as a whole. Multiple cross-sectional view
GSM (MCSV-GSM) imaging assesses the whole plaque and
allows a more focal assessment of plaque echomorphol-
ogy. Thus it has been suggested that this technique is
superior to SLV assessment.10 The aim of this study was to
assess the relationship of both SLV and MCSV-GSM in high
grade carotid stenoses to the presenting symptoms.
Materials and Methods
One hundred and fourteen carotid bifurcation plaques
causing 70e99% stenosis were studied in 99 patients (64
males, 35 females) referred for consideration of carotid
endarterectomy. Informed consent was obtained and the
study was approved by the Ethics Committee of the Leeds
Teaching Hospitals NHS Trust. A detailed neurological
history and examination were recorded with symptoms
classified as ocular (amaurosis fugax [sudden onset of
partial or complete uniocular visual loss lasting less than
1 h], or retinal artery occlusion), transient ischaemic attack
(TIA [sudden focal neurological deficit lasting less than 24 h
with no other apparent cause]), or stroke (defined similarly
to TIA but with symptoms lasting more than 24 h). Risk
factors for vascular disease and medications were docu-
mented. Patients with potential cardioembolic sources forsymptoms (concomitant cardiac arrhythmia on ECG or 24 h
Holter monitoring; atrial thrombus or septal defect on
cardiac ECHO) were excluded from the study. Plaques
causing symptoms >3 months previously were excluded as
we have previously reported GSM changes suggestive of
remodelling in this group.17 Plaques with severe calcifica-
tion precluding GSM assessment were also excluded. Cere-
bral haemorrhage and lacunar infarcts were excluded by
cerebral computerized tomography in patients with stroke.
Ultrasound protocol
The % carotid stenosis was determined using duplex criteria
for detecting more than 70% stenoses, validated within our
unit (internal carotid artery [ICA] peak systolic velocity [PSV-
ICA>180 cm/s], end-diastolic velocity [EDV-ICA>80 cm/s],
ratio of peak systolic velocity in the ICA and common carotid
artery [CCA] [PSV-ICA/CCA>4]).18 A subgroup with 80e99%
stenosis were also identified (PSV-ICA>250 cm/s; EDV-
ICA>100 cm/s).
Grey scale median (GSM) assessment of each plaque was
performed using a previously described method.10 Briefly,
patients were scanned by one of two ultrasonographers
(blinded to the clinical details) using a high resolution
scanner (Acuson 128 XP10) and a 5e7 MHz multifrequency
linear array probe. B-mode settings were fixed throughout
the study. The most informative single longitudinal view
(SLV; image with maximum plaque area) of the plaque was
obtained using colour duplex and the image ‘frozen’. In
order to determine plaque GSM by the technique of multiple
cross-sectional imaging the carotid bifurcation was located
with an axial sweep of the neck. The skin was marked at
5 mm intervals from this point and transverse colour flow
images were obtained at each pre-marked site throughout
the length of the plaque (5e8 multiple cross-sectional views
[MCSV] per plaque). After ‘freezing’ each colour image, the
colour-off facility of the scanner was used to obtain the grey
scale image of each view. These images were captured,
digitized in bitmap format by a commercially available
videograbber (Matrox Marvel G400 AGP, Matrox Graphics
Inc., Montreal, Canada) and downloaded to computer.
Images were normalized with computer software (MAT-
LAB 5.3), using two reference points (blood and adventitia)
to a set grey scale from 0 (black) to 255 (white). The GSM for
each transverse and the single longitudinal image were then
determined. Whilst the SLV-GSM provides a single, selected
measure of global plaque echolucency, MCSV analysis allows
identification of the transverse image with the lowest GSM
(MCSV-GSMmin) reflecting maximal focal echolucency.
Further, the difference in values between the transverse
imageswithmaximumandminimumGSM (MCSV-GSMmaxmin)
assesses plaque heterogeneity, which cannot be quantified
with SLV imaging. We have previously published satisfactory
correlations for intra- and inter-observer error for this
technique having analysed 50 randomly picked images by
one observer and repeated analysis one month later by the
same person, plus one additional observer. Mean bias
between two independent determinations of GSM was 0.538
(95%CI, 1.2 to þ2.3), and mean bias for repeat measure-
ments by the same observer was 0.469 (95% CI, 0.93 to
þ1.8).10 In addition, we have correlated low SLV-GSM and
MCSV-GSMmin values with histological plaque instability.17
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Figure 1 Comparison of GSM with plaque symptomatology.
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Chi-squared test was used to determine differences in
proportions. Kruskall Wallis test was used to compare age
between groups. The one-sample Kolmogorov test deter-
mined that GSM data was nonparametric and thus the
ManneWhitney U test (2 groups) and Kruskall Wallis test
(multiple groups) was used for comparative analysis.
Multivariate logistic regression analysis was performed to
assess the relative role of MCSV-GSMmin and MCSV-
GSMmaxmin in differentiating plaques causing amaurosis
fugax from asymptomatic plaques. P < 0.05 was considered
significant. Statistical tests were performed using SPSS 17.0
computer software.
Results
Of the 114 70e99% internal carotid arteries stenoses, 5
were excluded due to excessive calcification precluding
GSM assessment. Of the remaining 109, 58 had caused
symptoms within 3 months (41 hemispheric symptoms
within 3 months [15 stroke, 26 TIA], 17 ocular) and 51 were
asymptomatic. The groups were well matched for age, sex,
vascular risk factors, systemic atherosclerosis and medica-
tion (Table 1).
Plaques causing hemispheric symptoms had a signifi-
cantly lower SLV-GSM than either plaques causing amaurosis
fugax or asymptomatic plaques (12.7 [2.9e30.0] versus 38.9
[11.3e50.1]; P Z 0.03 and 31.5 [15.9e56.3]; P Z 0.002
respectively; Kruskall Wallis P Z 0.006). There was no
difference in SLV-GSM between plaques causing amaurosis
fugax and asymptomatic plaques (P Z 0.840). In contrast
both groups of symptomatic plaques could be distinguished
from asymptomatic plaques using MCSV-GSMmin (hemi-
spheric 2.0 [0.0e7.0], P Z 0.002 versus asymptomatic;
amaurosis fugax 5.5 [1.2e9.9], P Z 0.043 versus asymp-
tomatic; asymptomatic 11.0 [1.5e26.3]; Kruskall Wallis
P Z 0.004). Both groups of symptomatic plaques showed
a tendency towards increased heterogeneity when
compared to asymptomatic plaques (hemispheric 24.0
[11.0e38.0], P Z 0.240 versus asymptomatic; amaurosis
fugax 32.7 [15.5e53.8], P Z 0.011 versus asymptomatic;
asymptomatic 16.5 [7.5e29.3]; Kruskall Wallis P Z 0.039).
The tendency towards increased heterogeneity in plaquesTable 1 Comparison of patient demographics and risk factors w
Hemispheric
(n Z 41)
A
(
Age (range), years 73 (46e92) 6
Male sex 63% 7
Hypertension 63% 7
Diabetes mellitus 15% 0
Hypercholesterolaemia 80% 7
Current smoker 37% 3
Ischaemic heart disease 40% 4
Peripheral vascular disease 23% 1
Antiplatelet therapy 90% 9
Anticoagulation 10% 0
% stenosis (range) 80 (70e95) 8causing amaurosis fugax versus hemispheric symptoms did
not reach significance (P Z 0.126) (Fig. 1).
A scatter plot of plaque MCSV-GSMmin against MCSV-
GSMmaxmin showed poor correlation between these vari-
ables in all plaque subgroups (Fig. 2). Multivariate logistic
regression analysis confirmed MCSV-GSMmin as an indepen-
dent predictor of plaques causing amaurosis fugax versus
asymptomatic plaques. MCSV-GSMmaxmin was not predic-
tive in the multivariate model (Table 2).
Discussion
This is the first study to compare MCSV-GSM imaging in high
grade carotid plaques with presenting symptom. Patients
were well matched for demographics, vascular risk factors,
medications and degree of stenosis. Plaques causing
hemispheric symptoms demonstrated global echolucency
on SLV-GSM assessment where as those causing ocular
symptoms had a similar SLV-GSM to asymptomatic plaques.
A previous study using subjective criteria identified similar
results with 82% of 57 50e99% stenosis plaques causing
amaurosis fugax as complex heterogenous (low echo pools
in a lesion with high echo levels).19 This is in contrast to theith plaque symptomatology.
maurosis fugax
n Z 17)
Asymptomatic
(n Z 51)
P value
4 (55e83) 70 (48e86) 0.12
1% 57% 0.61
1% 71% 0.74
% 22% 0.10
6% 80% 0.77
5% 28% 0.74
3% 53% 0.60
4% 36% 0.29
3% 94% 0.73
% 6% 0.49
0 (70e95) 80 (70e99) 0.89
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Figure 2 Scatter plot comparing MSCV-GSMmin and MCSV-
GSMhet in asymptomatic plaques and those causing amaurosis
fugax.
Plaque Echomorphology and Presenting Symptom 137findings of Holdsworth et al. who subjectively classified
71.8% of 39 carotid plaques causing amaurosis fugax as type
I or II (predominantly echolucent) although the majority of
these plaques were also causing higher severity stenoses
(80e99%).15 In a previous objective GSM study of 295 pla-
ques, those causing amaurosis fugax were associated with
a lower SLV-GSM (and higher severity of stenosis) than those
causing either hemispheric symptoms or asymptomatic
plaques.20 Increasing levels of stenosis are associated with
plaque echolucency, perhaps explaining the results of the
latter 2 studies. In our study stenosis was not a confounding
factor as groups were well matched for this variable. MCSV-
GSMmin was lower in both groups of symptomatic plaques,
with increased heterogeneity (MCSV-GSMmaxmin) compared
to asymptomatic plaques, significantly so in those plaques
causing amuarosis fugax. This is in keeping with the findings
of a recent study using complex measures to assess
heterogeneity in plaque echotexture following SLV-GSM
assessment which demonstrated higher rates of embolic
cerebral infarction in homogenous, echolucent plaques.13
These data suggest that plaques causing amaurosis fugax
may be associated with only focal plaque echolucency,
which cannot be identified on SLV imaging alone when
compared with other plaque types of similar severity
stenosis. Further, there appears to be a difference in pla-
que morphology between plaques causing ocular and
cerebral symptoms which may explain the difference in
clinical risk of future stroke, and the lower risk of peri-
operative cerebral events in those plaques causing ocular
symptoms. A histological study of 526 carotid plaques
reported a trend towards increased fibrous tissue (36.1%
versus 30.3%) and reduced haemorrhage (60.8% versusTable 2 Multivariate logistic regression analysis assessing
differentiation of plaques causing amaurosis fugax versus
asymptomatic plaques.
Beta t P value
MCSV-GSMmin 0.367 4.016 <0.001
MCSV-GSMmaxmin 0.111 1.211 0.22969.7%) in plaques causing amaurosis fugax and hemispheric
TIAs respectively although this failed to reach statistical
significance.21 Another study of assessing 404 carotid
endarterectomy specimens concluded that those plaques
causing amaurosis fugax were phenotypically similar to
asymptomatic plaques.22 However, only the 5 mm section
of plaque with greatest plaque burden was analysed,
potentially missing localised instability elsewhere in the
plaque. We have previously published data comparing SLV-
GSM and MCSVmin-GSM to histological instability defined as
cap rupture or thinning in any of multiple transverse
sections taken at 4 mm intervals throughout the plaque.
This showed a reduction in GSM in plaques defined as
histologically unstable.17 It is therefore tempting to suggest
that focal echolucency leads to smaller platelet emboli,
rather than large emboli containing lipid and necrotic
debris which may be released during plaque disruption in
a plaque with more widespread instability.
One criticism of this study is that analysis of transverse
images at 5 mm intervals may miss focal plaque instability
in the regions between scanned images. Previous histo-
logical studies have determined that examination of the
carotid bifurcation is most representative of plaque
histology but sequential sections at 3 mm intervals from
the bifurcation are required to avoid missing focal areas
of instability.23 However, in that study this 3 mm interval
was not compared to wider serial examinations
throughout the plaque. The length of plaque interrogated
by each transverse image on ultrasonography is greater
than a 5 mm section examined histologically (1.7 mm
ultrasound slice thickness at a depth of 1 cm increasing
to 6 mm at 6 cm depth using the Acuson 128 XP10 and
5e7 MHz transducer). Therefore increased intervals
between images is less likely to miss more focal variations
in echomorphology.
Other methods assessing focal histology in plaques have
been described. Pedro et al. described assessment of the
percentage area of the plaque with echolucent pixels (P40)
and demonstrated greater P40 values in symptomatic pla-
ques.9 As yet this method has not been assessed in
differentiating plaques causing amaurosis fugax specifi-
cally but one would expect P40 values intermediate to
those of asymptomatic plaques and those leading to
hemispheric symptoms. Evolution of 3D ultrasound may
allow better resolution images for plaque characterisation
in the future.
The results of this study provide a plausible explanation
for differences in pre- and peri-operative stroke risk in
symptomatic plaques presenting with different symptoms.
Further, they support further trials of objective MCSV-GSM
assessment to identify plaques which are at high risk of
future symptoms, and perhaps to stratify risk associated
with operative or endovascular intervention.
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